Collectively, S&P 500 Companies Projected to Report a 3.8% Growth in Fourth Quarter Earnings

Research Driven Investing Provides Stocks Research on Advanced Micro Devices and Microsoft

Continue Reading

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Five Star Equities Provides Stock Research on Astex Pharmaceuticals and BioTime

Continue Reading

Strong Earnings and Positive Economic Data Sends S&P 500 Index to 5-Year High

Research Driven Investing Provides Stocks Research on 3M and Amazon

Continue Reading

Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash

Five Star Equities Provides Stock Research on Cyclacel Pharmaceuticals and DARA Biosciences

Continue Reading

Despite Posting Mixed Fourth Quarter Earnings U.S. Airlines Showing Investors Strong Gains in 2013

Five Star Equities Provides Stock Research on Southwest Airlines and United Continental Holdings

Continue Reading

S&P 500 Companies Projected to Report a 3.8% Growth in Earnings — S&P 500 Index at a 5-Year High

Research Driven Investing Provides Stocks Research on F5 Networks and Xerox

Continue Reading

Regional Banks Fourth Quarter Earnings Driven by Loan Growth

Research Driven Investing Provides Stocks Research on Firstmerit and KeyCorp

Continue Reading

Trucking Industry on the Upswing Heading Into 2013 as Truck Tonnage Index Rises for the First Time Since July

Research Driven Investing Provides Stocks Research on Con Way and Swift Transportation

Continue Reading

Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements

Five Star Equities Provides Stock Research on Questcor Pharmaceuticals and Sequenom

Continue Reading

Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand

Five Star Equities Provides Stock Research on Cytori Therapeutics and Peregrine Pharmaceuticals

Continue Reading